Skin Cancer, Acne, Skin Injury | Dermatology News, Treatment Studies

FEATURED CONTENT

Dermatologic Challenges to Preventing Antimicrobial Resistance During the COVID-19 Pandemic

The COVID-19 pandemic has illuminated an ongoing concern about antimicrobial resistance in dermatology and requires a recommitment from clinicians to follow guidelines that promote good stewardship.

more features >>

Video Series

Squamous Cell Carcinoma: Identification and Treatment

Lower Face Treatments With Neurotoxins

Reducing Pain and Discomfort During Cosmetic Injections

LATEST

Aesthetic Medicine

Treatment Options for Cutaneous Viral Warts in Children

Psoriasis

Bimekizumab Under Review for Plaque Psoriasis

Musculoskeletal Symptoms Predict Psoriatic Arthritis

Psoriasis

Lipid-Rich Necrotic Core Linked to Psoriasis Severity

Practice Management

Rates of COVID-19 Infection Higher in Blacks, Hispanics

Acne

Tazarotene 0.045% Lotion Effective Acne Treatment, Regardless of Race/Ethnicity

Acne

Zinc May Reduce Number of Inflammatory Papules in Patients With Acne

Acne

Acne Scars Improved With Er: YAG Laser Treatment

IL-6 blockade may have helped a patient with multiple myeloma recover from COVID-19, but larger studies are needed to prove efficacy.

Practice Management

COVID-19 Death Toll Nears 200,000 in the United States

Women are at higher risk of hyperthyroidism than men, although both sexes can be affected, with risk greatest in patients with a family history of Graves disease or other thyroid disorders.7 In patients with hyperthyroidism, epidermal thinning is the most commonly reported skin manifestation.8 Other skin anomalies include softness, excessive perspiration (ie, hyperhidrosis; pictured), and warmth, causing skin to feel like that of an infant.3 Itching, generalized pruritus, chronic urticaria, vitiligo, and diffuse skin pigmentation have also been reported.8 Dermal changes most commonly result from autoimmunity, rather than from hormones directly affecting the skin.3

General Dermatology

AbobotulinumtoxinA Treatment Leads to Positive Outcomes for Hyperhidrosis

HS is a chronic disease. One study reported an average disease duration of 19 years in 90% of the cohort.3 The estimated prevalence of HS varies from 0.05% to 4.1% because of the challenges of collecting data and the large number of undiagnosed cases.4,5 HS is a disease of young adults, generally appearing after puberty in the second and third decades, with a decreasing prevalence in older adults. The average age of onset is 23 years, and in young men, the disease can continue into old age.3 HS is rare in children, and when it does occur in childhood, it is often the result of widespread disease in a family with a history of HS. This occurs in an estimated 34% to 40% of cases 3 Women are disproportionately affected at 3 times the rate of men, and tend to have a milder disease course. African American and biracial ethnicity are also associated with higher prevalence.. 6 Although direct correlations have not been proven, cigarette smoking, obesity, and a range of comorbid conditions are often present in patients with HS.7

General Dermatology

Helping Clinicians Understand Patient Experiences With Hidradenitis Suppurativa

more news >>

Browse drugs by:

Brand Generic Disease

FEATURED CONTENT

Video Series

LATEST

Drug Lookup